Group A Streptococcus Gene Expression in Humans and Cynomolgus Macaques with Acute Pharyngitis

ABSTRACT The molecular mechanisms used by group A Streptococcus (GAS) to survive on the host mucosal surface and cause acute pharyngitis are poorly understood. To provide new information about GAS host-pathogen interactions, we used real-time reverse transcription-PCR (RT-PCR) to analyze transcripts of 17 GAS genes in throat swab specimens taken from 18 pediatric patients with pharyngitis. The expression of known and putative virulence genes and regulatory genes (including genes in seven two-component regulatory systems) was studied. Several known and previously uncharacterized GAS virulence gene regulators were highly expressed compared to the constitutively expressed control gene proS. To examine in vivo gene transcription in a controlled setting, three cynomolgus macaques were infected with strain MGAS5005, an organism that is genetically representative of most serotype M1 strains recovered from pharyngitis and invasive disease episodes in North America and Western Europe. These three animals developed clinical signs and symptoms of GAS pharyngitis and seroconverted to several GAS extracellular proteins. Real-time RT-PCR analysis of throat swab material collected at intervals throughout a 12-day infection protocol indicated that expression profiles of a subset of GAS genes accurately reflected the profiles observed in the human pediatric patients. The results of our study demonstrate that analysis of in vivo GAS gene expression is feasible in throat swab specimens obtained from infected human and nonhuman primates. In addition, we conclude that the cynomolgus macaque is a useful nonhuman primate model for the study of molecular events contributing to acute pharyngitis caused by GAS.

[1]  S. Barthold,et al.  Borrelia burgdorferi Population Kinetics and Selected Gene Expression at the Host-Vector Interface , 2002, Infection and Immunity.

[2]  E. Fikrig,et al.  Arthropod- and Host-Specific Borrelia burgdorferi bbk32 Expression and the Inhibition of Spirochete Transmission1 , 2000, The Journal of Immunology.

[3]  B. Kreikemeyer,et al.  Group A streptococcal growth phase‐associated virulence factor regulation by a novel operon (Fas) with homologies to two‐component‐type regulators requires a small RNA molecule , 2001, Molecular microbiology.

[4]  J. Musser,et al.  Multilocus analysis of extracellular putative virulence proteins made by group A Streptococcus: Population genetics, human serologic response, and gene transcription , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Pichichero,et al.  Group A beta-hemolytic streptococcal infections , 1998, Pediatrics in review.

[6]  S. Rothbard,et al.  TYPE-SPECIFIC PROTECTION AND IMMUNITY FOLLOWING INTRANASAL INOCULATION OF MONKEYS WITH GROUP A HEMOLYTIC STREPTOCOCCI , 1946, The Journal of experimental medicine.

[7]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[8]  H. Malke,et al.  Life in protein‐rich environments: the relA‐independent response of Streptococcus pyogenes to amino acid starvation , 2000, Molecular microbiology.

[9]  S. Hamada,et al.  Fba, a novel fibronectin‐binding protein from Streptococcus pyogenes, promotes bacterial entry into epithelial cells, and the fba gene is positively transcribed under the Mga regulator , 2001, Molecular microbiology.

[10]  A. Podbielski,et al.  Molecular characterization of a major serotype M49 group A streptococcal DNase gene (sdaD) , 1996, Infection and immunity.

[11]  C. Wolz,et al.  Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of α‐toxin during device‐related infection resolved by direct quantitative transcript analysis , 2001, Molecular microbiology.

[12]  J. Musser,et al.  Identification and Characterization of thescl Gene Encoding a Group A StreptococcusExtracellular Protein Virulence Factor with Similarity to Human Collagen , 2000, Infection and Immunity.

[13]  M. Mbow,et al.  Analysis of Borrelia burgdorferi gene expression during life cycle phases of the tick vector Ixodes scapularis. , 2001, Microbes and infection.

[14]  A. Feinstein,et al.  The role of tonsils in predisposing to streptococcal infections and recurrences of rheumatic fever. , 1970, The New England journal of medicine.

[15]  M. Cunningham,et al.  Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.

[16]  R. Kennedy,et al.  Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection , 2000, Cellular microbiology.

[17]  R. Zimmerman,et al.  Human streptococcal disease syndrome compared with observations in chimpanzees. II. Immunologic responses to induced pharyngitis and the effect of treatment. , 1970, The Journal of infectious diseases.

[18]  J. Musser,et al.  Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis , 2001, Nature Medicine.

[19]  V. Kapur,et al.  Repression of the Staphylococcus aureus Accessory Gene Regulator in Serum and In Vivo , 2002, Journal of bacteriology.

[20]  J. Musser,et al.  Postgenomic Analysis of Four Novel Antigens of Group A Streptococcus: Growth Phase-Dependent Gene Transcription and Human Serologic Response , 2002, Journal of bacteriology.

[21]  H. Malke,et al.  relA-Independent Amino Acid Starvation Response Network of Streptococcus pyogenes , 2001, Journal of bacteriology.

[22]  James R. Brown,et al.  A genomic analysis of two‐component signal transduction in Streptococcus pneumoniae , 2000, Molecular microbiology.

[23]  M. Federle,et al.  A Response Regulator That Represses Transcription of Several Virulence Operons in the Group A Streptococcus , 1999, Journal of bacteriology.

[24]  C. Wolz,et al.  Quantification of Bacterial Transcripts during Infection Using Competitive Reverse Transcription-PCR (RT-PCR) and LightCycler RT-PCR , 2001, Clinical Diagnostic Laboratory Immunology.

[25]  Tetsuya Hayashi,et al.  Complete Nucleotide Sequence of aStaphylococcus aureus Exfoliative Toxin B Plasmid and Identification of a Novel ADP-Ribosyltransferase, EDIN-C , 2001, Infection and Immunity.

[26]  V. DiRita,et al.  A Two-Component Regulatory System, CsrR-CsrS, Represses Expression of Three Streptococcus pyogenesVirulence Factors, Hyaluronic Acid Capsule, Streptolysin S, and Pyrogenic Exotoxin B , 1999, Infection and Immunity.

[27]  M. Wessels,et al.  Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus , 1998, Molecular microbiology.

[28]  June R. Scott,et al.  Regulation of mga Transcription in the Group A Streptococcus: Specific Binding of Mga within Its Own Promoter and Evidence for a Negative Regulator , 1999, Journal of bacteriology.

[29]  Morag R. Graham,et al.  Global differential gene expression in response to growth temperature alteration in group A Streptococcus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Björck,et al.  Protein GRAB of Streptococcus pyogenes Regulates Proteolysis at the Bacterial Surface by Binding α2-Macroglobulin* , 1999, The Journal of Biological Chemistry.

[31]  J. Musser.  Streptococcal superantigen, mitogenic factor, and pyrogenic exotoxin B expressed by Streptococcus pyogenes. Structure and function. , 1997, Preparative biochemistry & biotechnology.

[32]  P. Vanace,et al.  EXPERIMENTAL STREPTOCOCCAL INFECTION IN THE RHESUS MONKEY * , 1960, Annals of the New York Academy of Sciences.

[33]  M. Caparon,et al.  A role for Trigger Factor and an Rgg‐like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes , 1998, The EMBO journal.

[34]  Susan M. Butler,et al.  Host-induced epidemic spread of the cholera bacterium , 2002, Nature.

[35]  B. Guy,et al.  Assessment of Helicobacter pylori Gene Expression within Mouse and Human Gastric Mucosae by Real-Time Reverse Transcriptase PCR , 2001, Infection and Immunity.

[36]  A. Bretscher,et al.  Insight into the molecular basis of pathogen abundance: Group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Caparon,et al.  Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Musser,et al.  Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Pichichero,et al.  Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. , 2000, The Journal of infectious diseases.

[40]  C. Nast,et al.  Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis model. , 2002, The Journal of infectious diseases.

[41]  M. Van Ranst,et al.  Use of gDNA as internal standard for gene expression in staphylococci in vitro and in vivo. , 2002, Biochemical and biophysical research communications.

[42]  C. Chen,et al.  Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. , 1990, The Journal of biological chemistry.

[43]  J. Uhr,et al.  Experimental streptococcal infections in baboons. , 1969, Transplantation proceedings.

[44]  A. Svennerholm,et al.  The expression of the Helicobacter pylori genes ureA and nap is higher in vivo than in vitro as measured by quantitative competitive reverse transcriptase-PCR. , 2002, FEMS immunology and medical microbiology.

[45]  J. R. Scott,et al.  Streptococcus pyogenes infection in mice. , 1996, Microbial pathogenesis.

[46]  J. Musser,et al.  Virulence control in group A Streptococcus by a two-component gene regulatory system: Global expression profiling and in vivo infection modeling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Barthold,et al.  Acquisition dynamics of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis at the host-vector interface. , 2001, Vector borne and zoonotic diseases.

[48]  Bruce A. Roe,et al.  Complete genome sequence of an M1 strain of Streptococcus pyogenes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  R. Zimmerman,et al.  Induced group A beta-hemolytic streptococcic infection in chimpanzees. , 1970, Journal of the American Veterinary Medical Association.

[50]  G. Friou.  Experimental infection of the upper respiratory tract of young chimpanzees with group A hemolytic streptococci. , 1950, The Journal of infectious diseases.

[51]  J. Dale.  Group A streptococcal vaccines. , 1999, Infectious disease clinics of North America.

[52]  J. Roberts,et al.  Acute pharyngitis. , 2020, The New England journal of medicine.

[53]  L. Björck,et al.  The Regulator PerR Is Involved in Oxidative Stress Response and Iron Homeostasis and Is Necessary for Full Virulence of Streptococcus pyogenes , 2002, Infection and Immunity.

[54]  June R. Scott,et al.  Streptococcus pyogenesinfection in mice , 1996 .

[55]  A. Ogunniyi,et al.  The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo. , 2002, Microbiology.

[56]  J. R. Scott,et al.  Virulence of two Streptococcus pyogenes strains (types M1 and M3) associated with toxic-shock-like syndrome depends on an intact mry-like gene , 1993, Infection and immunity.

[57]  Yun-Xin Fu,et al.  Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves , 1999, Nature Network Boston.

[58]  J. R. Scott,et al.  Role of mga in growth phase regulation of virulence genes of the group A streptococcus , 1997, Journal of bacteriology.

[59]  M. Caparon,et al.  Aerotolerance and Peroxide Resistance in Peroxidase and PerR Mutants of Streptococcus pyogenes , 2000, Journal of bacteriology.

[60]  L. Wolff,et al.  Quantitative reverse transcription polymerase chain reaction analysis of Porphyromonas gingivalis gene expression in vivo. , 2002, Journal of microbiological methods.

[61]  J. Musser,et al.  Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease , 1995, Infection and immunity.